PDL BioPharma Announces Private Exchange of Approximately $86.1 Million of Convertible Notes Due 2024

INCLINE VILLAGE, Nev., Sept. 12, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has entered into separate privately negotiated transactions to exchange approximately $86.1 million in aggregate principal amount of its 2.75%...

from PR Newswire: https://ift.tt/2ZZ8kYP